Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan · Delayed Price · Currency is TWD 169.00
-1.50 (-0.88%)
At close: Dec 5, 2025
TPEX:6712 Market Cap
TPEX:6712 has a market cap or net worth of 14.8 billion as of December 5, 2025. Its market cap has increased by 1.11% in one year.
Market Cap
14.80B
Enterprise Value
14.49B
Revenue
1.01B
Ranking
n/a
PE Ratio
28.68
Stock Price
169.00
Market Cap Chart
Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 14.80B, an increase of 190.50%. That is a compound annual growth rate of 16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 14.80B | 4.56% |
| Dec 31, 2024 | 14.16B | -1.25% |
| Dec 29, 2023 | 14.34B | -4.57% |
| Dec 30, 2022 | 15.02B | 15.46% |
| Dec 30, 2021 | 13.01B | 32.03% |
| Dec 31, 2020 | 9.86B | 8.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 283.81B |
| PharmaEssentia | 191.95B |
| Lotus Pharmaceutical | 78.37B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 33.97B |
| Lin BioScience | 33.46B |
| Lumosa Therapeutics | 32.68B |
| Center Laboratories | 27.88B |